Adeno-associated virus gene therapy (Kings College London)

N/A

Report date: 2023/10/26 16:04:18

Base Information

Drug NameAdeno-associated virus gene therapy (Kings College London)
Drug Alias NameAAV gene therapy - Kings College London/PfizerResearch programme: adeno-associated virus gene therapy - Kings College London/Pfizer
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncKing'S College London
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inborn
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A